Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.55 USD
Change Today -0.05 / -1.09%
Volume 29.4K
MSLP On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

muscle pharm corp (MSLP) Snapshot

Open
$4.68
Previous Close
$4.60
Day High
$4.78
Day Low
$4.24
52 Week High
10/8/14 - $14.20
52 Week Low
03/17/15 - $2.78
Market Cap
62.4M
Average Volume 10 Days
17.6K
EPS TTM
$-1.86
Shares Outstanding
13.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MUSCLE PHARM CORP (MSLP)

muscle pharm corp (MSLP) Related Bloomberg News

View More Bloomberg News

muscle pharm corp (MSLP) Related Businessweek News

No Related Businessweek News Found

muscle pharm corp (MSLP) Details

MusclePharm Corporation develops, manufactures, markets, and distributes branded nutritional supplements in the United States and internationally. It offers a range of powders, capsules, tablets, and gels. The company’s MusclePharm Hybrid series products include Assault, Amino1, and Combat Protein Powder; MusclePharm core products comprise BCAA 3:1:2, CLA Core, and Fish Oil that balance the essentials to meet the day-in and day-out demands of athletes; and Arnold Schwarzenegger series physique supplements consist of protein gainers, muscle builders, multivitamins, and nitric oxide boosters. It also provides FitMiss, which is designed and formulated primarily for women lifestyle to cover various needs, including weight loss, multi-vitamins, protein shakes, detox, skin care, and pre-workout energy mixes. In addition, the company offers over-the-counter drugs and preparations, cosmetics, and natural supplements, as well as intends to develop, market, and sell apparel and accessories. MusclePharm Corporation sells its products to various fitness enthusiasts, such as football, combat sports, weight training, bodybuilding, runners, basketball, soccer, cross fit, golf, tennis, and volleyball, as well as outdoor activities, and athletic and recreational enthusiasts. The company was founded in 2008 and is headquartered in Denver, Colorado.

176 Employees
Last Reported Date: 03/16/15
Founded in 2008

muscle pharm corp (MSLP) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $639.1K
President, Director and Member of Strategic I...
Total Annual Compensation: $555.2K
Co-Founder and Executive Vice President of Br...
Total Annual Compensation: $382.8K
Chief Operating Officer
Total Annual Compensation: $313.5K
Compensation as of Fiscal Year 2014.

muscle pharm corp (MSLP) Key Developments

MusclePharm Corporation Appoints Ryan Drexler as Board of Directors and Chairman

The Board of Directors of MusclePharm Corporation appointed Ryan Drexler to its Board of Directors and elected Mr. Drexler as Chairman of the Board. The Board has determined that Mr. Drexler qualifies as an independent director under the rules of the NASDAQ Stock Market LLC. Ryan Drexler, is currently the Chief Executive Officer of Consac, LLC.

MusclePharm Corporation Announces Board and Committee Changes

On May 21, 2015, the Board of Directors of MusclePharm Corporation appointed Mr. Michael Doron as the Lead Director of the Board. On May 22, 2015 the Board appointed each of Noel Thompson and Stacey Jenkins and on May 27, 2015 the Board appointed William Bush to serve as independent members of the Board. Mr. Thompson shall serve as a member of the Board's Governance and Nominating Committee and Compensation Committee. Mr. Bush shall serve as Chairman of the Board's Audit Committee and as a member of the Board's Compensation Committee. Mr. Jenkins shall serve as Chairman of the Board's Governance and Nominating Committee and as a member of the Board's Audit Committee. Mr. Thompson currently serves as the CEO and Chief Investment Officer of Thompson Global LLC, and owner and operator of Thompson Global LP. Mr. Thompson also currently operates Thompson Global Sports which provides advisory, financing, and consulting services to investors and companies in the sports industry and Thompson Global Special Situations which participates as adviser, lender, and principle in commodity, energy, infrastructure projects globally. Mr. Thompson currently serves on the Board of Directors for the World Anti-Doping Agency Charitable Foundation. Mr. Thompson also serves on the Board of Trustees for The United States Olympic and Para Olympic Foundation, as an Executive Board member of the Board of Governors for the National Wrestling Hall of Fame, and on the Board Directors of Hofstra University Athletics and the Titan Mercury Wrestling Club. Mr. Thompson also sits on The Board of Directors for Beat The Streets NY, which develops the full athletic potential for inner city kids in NYC using wrestling as a vehicle. Mr. Jenkins currently serves as a senior attorney with Medicity Inc., a global leader in healthcare enablement software and services, where he focuses upon contract negotiation, technology and communication, and regulatory matters. On May 21, 2015, Messrs. Gregory Macosko, Daniel McClory and Andrew Lupo resigned from the Board of the company.

Muscle Pharm Corp. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Reaffirms Earnings Guidance for the Full Year of 2015

Muscle Pharm Corp. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net revenue of $41,322,000 against $50,209,000 a year ago. Loss from operations was $7,284,000 against income from operations of $2,424,000 a year ago. Loss before provision for income taxes was $7,467,000 against $2,768,000 a year ago. Net loss was $7,479,000 or $0.56 per basic and diluted share against $2,736,000 or $0.23 per diluted share a year ago. Adjusted LBITDA was $1,552,000 against adjusted EBITDA of $7,928,000 a year ago. The company reaffirmed earnings guidance for the full year of 2015. Net revenue is expected to be in the range of $210 million to $220 million. Sustainable gross margin is expected to be in the range of 31% to 33%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSLP:US $4.55 USD -0.05

MSLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Natural Grocers by Vitamin Cottage Inc $26.74 USD +5.21
Twinlab Consolidated Holdings Inc $1.60 USD 0.00
USANA Health Sciences Inc $124.65 USD -0.45
Vitamin Shoppe Inc $36.76 USD -0.17
View Industry Companies
 

Industry Analysis

MSLP

Industry Average

Valuation MSLP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 2.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MUSCLE PHARM CORP, please visit www.musclepharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.